Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.

MLA

Abramson, J. S., et al. “Peripheral T-Cell Lymphomas in a Large US Multicenter Cohort: Prognostication in the Modern Era Including Impact of Frontline Therapy.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 25, no. 11, Nov. 2014, pp. 2211–17. EBSCOhost, https://doi.org/10.1093/annonc/mdu443.

APA

Abramson, J. S., Feldman, T., Kroll-Desrosiers, A. R., Muffly, L. S., Winer, E., Flowers, C. R., Lansigan, F., Nabhan, C., Nastoupil, L. J., Nath, R., Goy, A., Castillo, J. J., Jagadeesh, D., Woda, B., Rosen, S. T., Smith, S. M., & Evens, A. M. (2014). Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 25(11), 2211–2217. https://doi.org/10.1093/annonc/mdu443

Chicago

Abramson, J S, T Feldman, A R Kroll-Desrosiers, L S Muffly, E Winer, C R Flowers, F Lansigan, et al. 2014. “Peripheral T-Cell Lymphomas in a Large US Multicenter Cohort: Prognostication in the Modern Era Including Impact of Frontline Therapy.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 25 (11): 2211–17. doi:10.1093/annonc/mdu443.